BSE Live
Nov 14, 16:01Prev. Close
417.05
Open Price
415.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 14, 15:57Prev. Close
417.00
Open Price
414.75
Bid Price (Qty.)
411.15 (7561)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Biocon (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 1,429.40 | 1,297.80 | 643.00 | 771.60 | 846.20 | |
| Net CashFlow From Operating Activities | 4,061.20 | 2,953.90 | 1,852.50 | 1,176.60 | 1,159.70 | |
| Net Cash Used In Investing Activities | -234.10 | -1,004.50 | -14,281.80 | -1,699.10 | -3,624.70 | |
| Net Cash Used From Financing Activities | -1,854.00 | -2,332.70 | 13,048.70 | 242.10 | 2,564.00 | |
| Foreign Exchange Gains / Losses | 31.20 | 2.90 | 21.70 | 3.30 | 7.10 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 33.80 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 2,004.30 | -380.40 | 641.10 | -243.30 | 106.10 | |
| Cash And Cash Equivalents Begin of Year | 919.50 | 1,299.90 | 653.70 | 897.00 | 790.90 | |
| Cash And Cash Equivalents End Of Year | 2,923.80 | 919.50 | 1,294.80 | 653.70 | 897.00 |
14.11.2025
12.11.2025
Biocon Standalone September 2025 Net Sales at Rs 583.30 crore, up 11.02% Y-o-Y
10.11.2025
07.11.2025